Bioventus Inc - Class A — Quarterly Financial Statistics (NASDAQ:BVS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 10.32 M19.32 M-19.33 M25.94 M30.1 M 56.03 M Cash from investing activities -64 K24.1 M-826 K-1.37 M-473 K 21.44 M Cash from financing activities 362 K-42.85 M947 K-14.66 M-19.98 M -76.55 M Free cash flow 10.25 M18.75 M-20.16 M25.25 M29.63 M 53.47 M

뉴스

Bravura Solutions: Umsatzplus von 9,8 % und angehobene Prognose für 2026

Bravura Solutions 1H26 presentation: Revenue up 9.8%, guidance upgraded

Bravura Solutions: Umsatz- und Ergebniswachstum im ersten Halbjahr 2026

Earnings call transcript: Bravura Solutions’ H1 2026 highlights revenue growth

Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:BVS) 2026-01-15

Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Bioventus Inc. (BVS) Presents at Piper Sandler 37th Annual Healthcare Conference - Slideshow (NASDAQ:BVS) 2025-12-04

Bioventus beruft Ajay Dhankhar in den Verwaltungsrat/n

Bioventus appoints Ajay Dhankhar to board as Class II director

Bioventus Q3 2025: Organisches Wachstum von 8 % und Margensteigerung trotz stagnierender Umsätze

Palantir, Uber among market cap stock movers on Tuesday

Bioventus Q3 2025 slides: 8% organic growth with margins expanding despite flat revenue